RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Jianying Zhang to Humans

This is a "connection" page, showing publications Jianying Zhang has written about Humans.
Connection Strength

0.828
  1. Qiu C, Ma Y, Wang B, Zhang X, Wang X, Zhang JY. Autoantibodies to PAX5, PTCH1, and GNA11 as Serological Biomarkers in the Detection of Hepatocellular Carcinoma in Hispanic Americans. Int J Mol Sci. 2023 Feb 13; 24(4).
    View in: PubMed
    Score: 0.041
  2. Zhang X, Xing M, Ma Y, Zhang Z, Qiu C, Wang X, Zhao Z, Ji Z, Zhang JY. Oridonin Induces Apoptosis in Esophageal Squamous Cell Carcinoma by Inhibiting Cytoskeletal Protein LASP1 and PDLIM1. Molecules. 2023 Jan 13; 28(2).
    View in: PubMed
    Score: 0.041
  3. Ma Y, Qiu C, Wang B, Zhang X, Wang X, Aguilera RJ, Zhang JY. Autoantibody against Tumor-Associated Antigens as Diagnostic Biomarkers in Hispanic Patients with Hepatocellular Carcinoma. Cells. 2022 10 14; 11(20).
    View in: PubMed
    Score: 0.041
  4. Zhang J, Zhang B, Zhang Y. Cancer Immunology and Cancer Immunodiagnosis 2016. J Immunol Res. 2017; 2017:9127382.
    View in: PubMed
    Score: 0.027
  5. Dai L, Tsay JC, Li J, Yie TA, Munger JS, Pass H, Rom WN, Zhang Y, Tan EM, Zhang JY. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer. 2016 09; 99:172-9.
    View in: PubMed
    Score: 0.026
  6. Dai L, Li J, Xing M, Sanchez TW, Casiano CA, Zhang JY. Using Serological Proteome Analysis to Identify Serum Anti-Nucleophosmin 1 Autoantibody as a Potential Biomarker in European-American and African-American Patients With Prostate Cancer. Prostate. 2016 11; 76(15):1375-86.
    View in: PubMed
    Score: 0.026
  7. Li J, Dai L, Lei N, Xing M, Li P, Luo C, Casiano CA, Zhang JY. Evaluation and characterization of anti-RalA autoantibody as a potential serum biomarker in human prostate cancer. Oncotarget. 2016 Jul 12; 7(28):43546-43556.
    View in: PubMed
    Score: 0.026
  8. Dai L, Peng XX, Tan EM, Zhang JY. Tumor-associated antigen CAPERa and microvessel density in hepatocellular carcinoma. Oncotarget. 2016 Mar 29; 7(13):16985-95.
    View in: PubMed
    Score: 0.026
  9. Peng B, Chai Y, Li Y, Liu X, Zhang J. CIP2A overexpression induces autoimmune response and enhances JNK signaling pathway in human lung cancer. BMC Cancer. 2015 Nov 11; 15:895.
    View in: PubMed
    Score: 0.025
  10. Li Y, Francia G, Zhang JY. p62/IMP2 stimulates cell migration and reduces cell adhesion in breast cancer. Oncotarget. 2015 Oct 20; 6(32):32656-68.
    View in: PubMed
    Score: 0.025
  11. Zhou JW, Li Y, Yue LX, Luo CL, Chen Y, Zhang JY. Autoantibody response to Sui1 and its tissue-specific expression in hepatocellular carcinoma. Tumour Biol. 2016 Feb; 37(2):2547-53.
    View in: PubMed
    Score: 0.025
  12. Liu Y, Dai L, Liu W, Shi G, Zhang J. Autoantibody to MDM2: A Potential Serological Marker of Systemic Lupus Erythematosus. J Immunol Res. 2015; 2015:963568.
    View in: PubMed
    Score: 0.024
  13. Zhu Q, Han SX, Zhou CY, Cai MJ, Dai LP, Zhang JY. Autoimmune response to PARP and BRCA1/BRCA2 in cancer. Oncotarget. 2015 May 10; 6(13):11575-84.
    View in: PubMed
    Score: 0.024
  14. Liu M, Varela-Ramirez A, Li J, Dai L, Aguilera RJ, Zhang JY. Humoral autoimmune response to nucleophosmin in the immunodiagnosis of hepatocellular carcinoma. Oncol Rep. 2015 May; 33(5):2245-52.
    View in: PubMed
    Score: 0.024
  15. Peng B, Lei N, Chai Y, Chan EK, Zhang JY. CIP2A regulates cancer metabolism and CREB phosphorylation in non-small cell lung cancer. Mol Biosyst. 2015 Jan; 11(1):105-14.
    View in: PubMed
    Score: 0.023
  16. Liu X, Peng B, Li Y, Lei N, Li W, Zhang JY. p90/CIP2A mediates breast cancer cell proliferation and apoptosis. Mol Biol Rep. 2014 Nov; 41(11):7471-8.
    View in: PubMed
    Score: 0.023
  17. Li Y, Zhang Q, Peng B, Shao Q, Qian W, Zhang JY. Identification of glutathione S-transferase omega 1 (GSTO1) protein as a novel tumor-associated antigen and its autoantibody in human esophageal squamous cell carcinoma. Tumour Biol. 2014 Nov; 35(11):10871-7.
    View in: PubMed
    Score: 0.023
  18. Lei N, Peng B, Zhang JY. CIP2A regulates cell proliferation via the AKT signaling pathway in human lung cancer. Oncol Rep. 2014 Oct; 32(4):1689-94.
    View in: PubMed
    Score: 0.023
  19. Liu M, Zheng SJ, Chen Y, Li N, Ren PF, Dai LP, Duan ZP, Zhang JY. Autoantibody response to murine double minute 2 protein in immunodiagnosis of hepatocellular carcinoma. J Immunol Res. 2014; 2014:906532.
    View in: PubMed
    Score: 0.023
  20. Liu X, Ye H, Li L, Li W, Zhang Y, Zhang JY. Humoral autoimmune responses to insulin-like growth factor II mRNA-binding proteins IMP1 and p62/IMP2 in ovarian cancer. J Immunol Res. 2014; 2014:326593.
    View in: PubMed
    Score: 0.023
  21. Dai L, Li J, Ortega R, Qian W, Casiano CA, Zhang JY. Preferential autoimmune response in prostate cancer to cyclin B1 in a panel of tumor-associated antigens. J Immunol Res. 2014; 2014:827827.
    View in: PubMed
    Score: 0.022
  22. Dai L, Ren P, Liu M, Imai H, Tan EM, Zhang JY. Using immunomic approach to enhance tumor-associated autoantibody detection in diagnosis of hepatocellular carcinoma. Clin Immunol. 2014 May-Jun; 152(1-2):127-39.
    View in: PubMed
    Score: 0.022
  23. Chai Y, Liu X, Dai L, Li Y, Liu M, Zhang JY. Overexpression of HCC1/CAPERa may play a role in lung cancer carcinogenesis. Tumour Biol. 2014 Jul; 35(7):6311-7.
    View in: PubMed
    Score: 0.022
  24. Zhu Q, Liu M, Dai L, Ying X, Ye H, Zhou Y, Han S, Zhang JY. Using immunoproteomics to identify tumor-associated antigens (TAAs) as biomarkers in cancer immunodiagnosis. Autoimmun Rev. 2013 Oct; 12(12):1123-8.
    View in: PubMed
    Score: 0.021
  25. Peng B, Huang X, Nakayasu ES, Petersen JR, Qiu S, Almeida IC, Zhang JY. Using immunoproteomics to identify alpha-enolase as an autoantigen in liver fibrosis. J Proteome Res. 2013 Apr 05; 12(4):1789-96.
    View in: PubMed
    Score: 0.021
  26. Zhang JY, Tan EM. Autoantibodies to tumor-associated antigens as diagnostic biomarkers in hepatocellular carcinoma and other solid tumors. Expert Rev Mol Diagn. 2010 Apr; 10(3):321-8.
    View in: PubMed
    Score: 0.017
  27. Chen Y, Zhou Y, Qiu S, Wang K, Liu S, Peng XX, Li J, Tan EM, Zhang JY. Autoantibodies to tumor-associated antigens combined with abnormal alpha-fetoprotein enhance immunodiagnosis of hepatocellular carcinoma. Cancer Lett. 2010 Mar 01; 289(1):32-9.
    View in: PubMed
    Score: 0.016
  28. Zhang JY, Looi KS, Tan EM. Identification of tumor-associated antigens as diagnostic and predictive biomarkers in cancer. Methods Mol Biol. 2009; 520:1-10.
    View in: PubMed
    Score: 0.016
  29. Looi KS, Nakayasu ES, Diaz RA, Tan EM, Almeida IC, Zhang JY. Using proteomic approach to identify tumor-associated antigens as markers in hepatocellular carcinoma. J Proteome Res. 2008 Sep; 7(9):4004-12.
    View in: PubMed
    Score: 0.015
  30. Chen Y, Lin P, Qiu S, Peng XX, Looi K, Farquhar MG, Zhang JY. Autoantibodies to Ca2+ binding protein Calnuc is a potential marker in colon cancer detection. Int J Oncol. 2007 May; 30(5):1137-44.
    View in: PubMed
    Score: 0.014
  31. Looi K, Megliorino R, Shi FD, Peng XX, Chen Y, Zhang JY. Humoral immune response to p16, a cyclin-dependent kinase inhibitor in human malignancies. Oncol Rep. 2006 Nov; 16(5):1105-10.
    View in: PubMed
    Score: 0.013
  32. Zhang JY. Mini-array of multiple tumor-associated antigens to enhance autoantibody detection for immunodiagnosis of hepatocellular carcinoma. Autoimmun Rev. 2007 Jan; 6(3):143-8.
    View in: PubMed
    Score: 0.013
  33. Zhang JY, Megliorino R, Peng XX, Tan EM, Chen Y, Chan EK. Antibody detection using tumor-associated antigen mini-array in immunodiagnosing human hepatocellular carcinoma. J Hepatol. 2007 Jan; 46(1):107-14.
    View in: PubMed
    Score: 0.013
  34. Megliorino R, Shi FD, Peng XX, Wang X, Chan EK, Tan EM, Zhang JY. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection. Cancer Detect Prev. 2005; 29(3):241-8.
    View in: PubMed
    Score: 0.012
  35. Zhang JY. Tumor-associated antigen arrays to enhance antibody detection for cancer diagnosis. Cancer Detect Prev. 2004; 28(2):114-8.
    View in: PubMed
    Score: 0.011
  36. Sanchez TW, Zhang G, Li J, Dai L, Mirshahidi S, Wall NR, Yates C, Wilson C, Montgomery S, Zhang JY, Casiano CA. Immunoseroproteomic Profiling in African American Men with Prostate Cancer: Evidence for an Autoantibody Response to Glycolysis and Plasminogen-Associated Proteins. Mol Cell Proteomics. 2016 Dec; 15(12):3564-3580.
    View in: PubMed
    Score: 0.007
  37. Sun W, Tseng TB, Zhang J, Qian W. Enhancing deep convolutional neural network scheme for breast cancer diagnosis with unlabeled data. Comput Med Imaging Graph. 2017 04; 57:4-9.
    View in: PubMed
    Score: 0.007
  38. Sun W, Tseng TL, Zhang J, Qian W. Computerized breast cancer analysis system using three stage semi-supervised learning method. Comput Methods Programs Biomed. 2016 Oct; 135:77-88.
    View in: PubMed
    Score: 0.007
  39. Luo CL, Liu YQ, Wang P, Song CH, Wang KJ, Dai LP, Zhang JY, Ye H. The effect of quercetin nanoparticle on cervical cancer progression by inducing apoptosis, autophagy and anti-proliferation via JAK2 suppression. Biomed Pharmacother. 2016 Aug; 82:595-605.
    View in: PubMed
    Score: 0.007
  40. Sun W, Tseng TL, Qian W, Zhang J, Saltzstein EC, Zheng B, Lure F, Yu H, Zhou S. Using multiscale texture and density features for near-term breast cancer risk analysis. Med Phys. 2015 Jun; 42(6):2853-62.
    View in: PubMed
    Score: 0.006
  41. Liu M, Zheng SJ, Xu W, Zhang J, Chen Y, Duan Z. Changing interdigestive migrating motor complex in rats under acute liver injury. Biomed Res Int. 2014; 2014:634281.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support